Keywords: galvus, cuts, blood, sugar, type, diabetes, swiss

Galvus cuts blood sugar in type 2 diabetes

Article | 02 July 2007

Print This

Swiss drug major Novartis has reported data which show that its diabetes treatment Galvus (vildagliptin) brought about consistent and robust ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in